Now that there are several targeted biotech drugs on the market, researchers are starting to test whether two targeted drugs are better than one. 既然市場(chǎng)上有很多靶向生物技術(shù)藥物，那么研究者正開(kāi)始試驗兩個(gè)靶向藥物是否會(huì )比一個(gè)更好些。
Preliminary research suggests that mitochondria-rejuvenating drugs are capable, at least in lab animals, of halting these diseases and extending longevity. 初步研究表明，線(xiàn)粒體靶向藥物是有效的，至少在動(dòng)物實(shí)驗中證明它可以制止這些疾病并延長(cháng)壽命。
